News
According to reports, an estimated 7.74 million people lived with sickle cell disease in 2021. Sickle cell anaemia can be a ...
Paris: Sanofi has received orphan drug designation from the US Food and Drug Administration (FDA) for rilzabrutinib, a novel, ...
Rilzabrutinib granted orphan drug designation in the US for sickle cell disease <li /> Fourth orphan drug designation for rilzabrutinib ...
12h
Zacks Investment Research on MSNSNY's Rilzabrutinib Wins 4th Orphan Drug Tag for Sickle Cell DiseaseSanofi SNY announced that the FDA has granted orphan drug designation to its investigational BTK inhibitor, rilzabrutinib, ...
4d
The Punch on MSNSickle cell disease and knee joint pain: Why steriods aren’t always the best optionFor people living with sickle cell disease, joint pain, especially in the knees, can be a frustrating and persistent companion.When swelling and fluid build-up occur in the joint, doctors often ...
Researchers have discovered a breakthrough link between organ failure and long Covid after overcoming contentious Covid-era ...
Researchers evaluated the use of ultrawide field swept-source OCT-A to evaluate retinal vasculature in patients with sickle cell retinopathy.
Forget the hyper-volatile, high-profile stock names. In this environment, lesser-known and less-exciting stocks are apt to ...
Columnist Oluwatosin Adesoye explains why preventing malaria infections is particularly important for those with sickle cell ...
7h
News Medical on MSNFDA approves a first-of-its-kind eye implant that slows vision loss in rare eye diseaseFor people diagnosed with macular telangiectasia type 2 (MacTel)—a rare and slowly progressing retinal disease—there have ...
Sickle cell disease (SCD) affects an estimated 20 million people worldwide. As a genetic condition that leads to severe, lifelong complications, SCD remains a significant unmet medical need with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results